ABCG2 and acute myeloid leukemia: A negative impact of ABCG2 overexpression on disease outcome was reported by Benderra et al., in 149 adult AML patients, as high ABCG2 expression correlated with lower CR rate (p = 0.04) and OS (p = 0.05) compared to non-overexpressing patients.